|
Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Business Market Research
Energy Market Research
Financial Market Research
Pharmaceutical Market Research
Telecoms Market Research
|
Home > Market Research > Prescription Medicines > Contract Pharmaceutical Manufacturing, Research, and Packaging
REPORT HIGHLIGHTS
Worldwide revenue for contract manufacture of prescription drugs (dosage forms) for 2004 was $11.1 billion, which is projected to increase at a compound annual growth rate (CAGR) of 9.4%, reaching $22.5 billion by the end of 2011.
Contract manufacture of over-the-counter and nutritional products worldwide is projected to reach $108.8 billion by 2011 increasing at a CAGR of 8.1%. Contract research revenues are projected to reach $24.3 billion by 2011, increasing from $17.3 billion in 2006 at a CAGR of 7.0%.
Contract manufacturing in the bulk drug market had worldwide revenue of about $13.5 billion in 2004
INTRODUCTION
BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for contract manufacturing, research, and packaging in the pharmaceutical business. The key objective is to present a comprehensive analysis of the current market and its future direction in the pharmaceutical outsourcing industry with the emphasis on contract manufacturing.
This report explores present and future strategies within the contract manufacturing, research, and packaging pharmaceutical industry. Definitions, needs, requirements, and the advantages and disadvantages of outsourcing are discussed. The study also includes market forecasts and a discussion of the market leaders in the industry. Risks involved, regulatory requirements, and technologies involved are crucial components of this market outlook.
Influential market scenarios such as the need for contract manufacturing, research, selection of contractors, etc. have been included, along with a detailed analysis of the pharmaceutical/biopharmaceutical contract manufacturing, research, and packaging industry structure. Revenues are broken down by the bulk as well as by dosage forms of solid, liquid, and semisolid. Sales figures are estimated for the 5-year period from 2006 through 2011.
Over-the-counter (OTC), nutritional, and drug delivery products are discussed separately in this report. Contract research and contract packaging are also discussed separately
SCOPE OF STUDY
This report contains:
The current market status for contract manufacturing, research, and packaging and forecasts for growth through 2011
Discussion of the advantages and disadvantages of outsourcing
Technological issues including the latest trends and developments
Descriptions of each market's need for outsourcing, risks and regulatory environment.
A break down of revenues by the bulk as well as by the dosage forms of solid, liquid and semisolid.
METHODOLOGY
BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical/chemical/pharmaceutical and contracting experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
INFORMATION SOURCES
Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of pharmaceuticals through contract manufacturing/research. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.
Top of Page
Table of Contents
INTRODUCTION
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
DISCLAIMER
EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT
MANUFACTURING AND CONTRACT RESEARCH
ORGANIZATIONS REVENUE FORECAST, THROUGH 2011 ($
BILLIONS)
SUMMARY FIGURE WORLDWIDE PHARMACEUTICAL CONTRACT
MANUFACTURING AND CONTRACT RESEARCH
ORGANIZATIONS REVENUE, 2004-2011 (BILLIONS)
OVERVIEW
DEFINITIONS
CONTRACT MANUFACTURING
CONTRACT RESEARCH
CONTRACT PACKAGING
PACKAGING SERVICE SELECTION CRITERIA
ADVANTAGES OF CONTRACT PACKAGING
NEED FOR OUTSOURCING
NEED FOR CONTRACT MANUFACTURING
Flexibility
Capacity and Capital
Risks
NEED FOR CONTRACT RESEARCH
NEED FOR CONTRACT PACKAGING
CAPABILITIES AND QUALITIES OF CONTRACT COMPANIES
PROS AND CONS OF OUTSOURCING
ADVANTAGES OF OUTSOURCING
DISADVANTAGES OF OUTSOURCING
CONTRACT REQUIREMENTS
BASIC RISKS IN OUTSOURCING PARTNERSHIPS
KEYS TO REDUCING RISKS
KEYS TO CONTRACT ORGANIZATIONS MEETING
CHALLENGES IN QUALITY AND REGULATORY
REQUIREMENTS
TECHNOLOGY
INTRODUCTION
SELECTION OF AN OUTSOURCING PROVIDER
CONTRACT MANUFACTURING ORGANIZATION
REQUIREMENTS
Term Sheet
Manufacturing Agreement between the Parties
Quality Agreement
Technology Transfer
Information Exchange
Process Design and Process Logistics
Process Description
Production Requirements Plan
Reviewing Production Details
Perform Transfer Runs
Implementation of the Production Requirements
Plan
Training
Keys to a Good Relationship
Client Involvement in Technology Transfer
Team Meetings
Management’s Involvement
Contract Manufacturing Agreement
Role of the Project Manager
Role of the Project Manager (Continued)
REGULATORY ASPECTS
REGULATORY COMPLIANCE REQUIREMENTS
AGREEMENT BETWEEN CONTRACTOR AND CLIENT TO
MEET REGULATIONS
REGULATORY ISSUES IN CONTRACT MANUFACTURING
USE OF CONSULTING FIRMS
REGULATION OF API/BULK DRUG MANUFACTURING
INDUSTRY STRUCTURE
MARKET SHARES OF INDUSTRY LEADERS
CONTRACT MANUFACTURERS OF BULK DRUGS AND APIS
TABLE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2006 (%)
TABLE 1 (CONTINUED)
FIGURE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2006 (%)
CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS
TABLE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2006 (%)
FIGURE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2006 (%)
CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
TABLE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID DOSAGE FORMS, 2006 (%)
FIGURE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID DOSAGE FORMS, 2006 (%)
CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS
TABLE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2006 (%)
FIGURE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2006 (%)
CONTRACT RESEARCH COMPANIES
TABLE 5 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2006 (%)
FIGURE 5 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2006 (%)
CONTRACT PACKAGING COMPANIES
TABLE 6 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2006 (%)
FIGURE 6 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2006 (%)
TYPES OF CONTRACT MANUFACTURING AND RESEARCH FIRMS
TABLE 7 SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS
TABLE 7 (CONTINUED)
TABLE 7 (CONTINUED)
TABLE 7 (CONTINUED)
TABLE 7 (CONTINUED)
TABLE 7 (CONTINUED)
TABLE 7 (CONTINUED)
TABLE 8 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE
SUPPLY AND DEMAND
STRATEGIC TOOLS
TIME TO MARKET
CHALLENGES IN OUTSOURCING
IDENTIFICATION OF OUTSOURCING PARTNERS
FINANCIAL CONSIDERATIONS
PREFERRED PROVIDERS
INNOVATIVE PARTNERS
SUITABLE ALTERNATIVES
NEW DEVELOPMENTS
ABBOTT LABORATORIES
ALBANY MOLECULAR RESEARCH (AMRI)
ASTELLAS PHARMA
CAMBREX
CARDINAL HEALTH
CHEMBRIDGE
GLAXOSMITHKLINE (GSK)
MALLINCKRODT, INC.
PATHEON
SCHWARZ PHARMA
MARKETS
BACKGROUND
CONTRACT MANUFACTURING
CONTRACT MANUFACTURE OF BULK DRUGS/APIS
Contract Manufacture of ? (Continued)
Role of APIs in the Success of Generic Firms
Role of Contract Manufacturer in API Product
Development
Market Leaders
Market Revenue
TABLE 9 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING REVENUE FORECAST BY REGION THROUGH 2011 ($ BILLIONS)
FIGURE 7 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ BILLIONS)
Market Shares
TABLE 10 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 8 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
CONTRACT MANUFACTURE OF ORAL DOSAGE
FORMULATIONS
Solid Dosage Formulations
Market Leaders
Market Revenue
TABLE 11 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)
FIGURE 9 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 (BILLIONS)
Market Shares
TABLE 12 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 10 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
Market by Formulation
Market Revenue
TABLE 13 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, THROUGH 2011 ($ BILLIONS)
FIGURE 11 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, 2004-2011 ($ BILLIONS)
TABLE 14 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
FIGURE 12 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING, MARKET SHARES BY FORMULATION, 2006 (%)
CONTRACT MANUFACTURE OF LIQUID DOSAGE
FORMULATIONS
Non-sterile Formulations
Market Revenue
TABLE 15 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2011 ($ MILLIONS)
FIGURE 13 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2004-2011 ($ MILLIONS)
Market Shares
TABLE 16 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 14 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
Sterile Formulations
Market Leaders
Market Revenue
TABLE 17 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST, BY REGION, THROUGH 2011 ($ MILLIONS)
FIGURE 15 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST, BY REGION, THROUGH 2011 ($ MILLIONS)
Market Shares
TABLE 18 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 16 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
Market by Formulation
Non-sterile Formulations
TABLE 19 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE FORECAST, BY FORMULATION, THROUGH 2011 ($ MILLIONS)
FIGURE 17 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2004-2011 ($ MILLIONS)
TABLE 20 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
FIGURE 18 GLOBAL LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
Sterile Formulations
TABLE 21 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, THROUGH 2011 ($ MILLIONS)
FIGURE 19 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, 2004-2011 ($ MILLIONS)
TABLE 22 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
FIGURE 20 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
CONTRACT MANUFACTURE OF SEMISOLID DOSAGE
FORMULATIONS
Market Leaders
Market Revenue
TABLE 23 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
FIGURE 21 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)
Market Shares
TABLE 24 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 22 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
Market by Formulation
TABLE 25 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, THROUGH 2011 ($ MILLIONS)
FIGURE 23 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, 2004-2011 ($ MILLIONS)
TABLE 26 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
FIGURE 24 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
CONTRACT MANUFACTURE OF ADVANCED DRUG
DELIVERY PRODUCTS
Contract Manufacture of?(Continued)
Partnerships
Market Leaders
TABLE 27 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS
Market Outlook
Market Revenue
TABLE 28 GLOBAL CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE FORECAST BY TYPE, THROUGH 2011 ($ BILLIONS)
FIGURE 25 GLOBAL ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE FORECAST BY TYPE, 2004-2011 ($ BILLIONS)
Market Shares
TABLE 29 GLOBAL ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING SHARE BY TYPE, 2006 (%)
FIGURE 26 GLOBAL ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2006 (%)
CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL
PRODUCTS
Market Leaders
Market Revenue
TABLE 30 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)
FIGURE 27 GLOBAL OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ BILLIONS)
Market Shares
TABLE 31 GLOBAL OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 28 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
Market by Formulation
TABLE 32 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE FORECAST BY DOSAGE FORM, THROUGH 2011 ($ BILLIONS)
FIGURE 29 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE FORECAST BY DOSAGE FORM, 2004-2011 ($ BILLIONS)
TABLE 33 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2006 (%)
FIGURE 30 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2006 (%)
CONTRACT RESEARCH
MARKET LEADERS
MARKET OUTLOOK
MARKET REVENUE
TABLE 34 GLOBAL CONTRACT PHARMACEUTICAL RESEARCH MARKET FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)
FIGURE 31 GLOBAL CONTRACT PHARMACEUTICAL RESEARCH MARKET FORECAST BY REGION, 2004-2011 ($ BILLIONS)
MARKET SHARES
TABLE 35 GLOBAL CONTRACT RESEARCH MARKET SHARES BY REGION, 2006 (%)
FIGURE 32 GLOBAL CONTRACT RESEARCH MARKET SHARES BY REGION, 2006 (%)
MARKET BY DISCIPLINE
TABLE 36 GLOBAL CONTRACT RESEARCH REVENUE FORECAST BY DISCIPLINE, THROUGH 2011 ($ BILLIONS)
FIGURE 33 GLOBAL CONTRACT RESEARCH REVENUE FORECAST BY DISCIPLINE, 2004-2011 ($ BILLIONS)
MARKET SHARES BY DISCIPLINE
TABLE 37 GLOBAL CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2006 (%)
FIGURE 34 GLOBAL CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2006 (%)
CONTRACT PACKAGING
MARKET LEADERS
MARKET REVENUE
TABLE 38 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)
FIGURE 35 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY REGION, 2004-2011 ($ BILLIONS)
MARKET SHARES
TABLE 39 GLOBAL CONTRACT PACKAGING MARKET SHARES BY REGION, 2006 (%)
FIGURE 36 GLOBAL CONTRACT PACKAGING MARKET SHARES BY REGION, 2006 (%)
MARKET BY PACKAGE TYPE
MARKET REVENUE
TABLE 40 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY PACKAGE TYPE, THROUGH 2011 ($ BILLIONS)
FIGURE 37 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY PACKAGE TYPE, 2004-2011 ($ BILLIONS)
MARKET SHARES
TABLE 41 GLOBAL CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2006 (%)
FIGURE 38 GLOBAL CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2006 (%)
CONTRACT MANUFACTURING APPLICATIONS
CARDIOVASCULAR DRUG MARKET
MARKET REVENUE
TABLE 42 GLOBAL CONTRACT MANUFACTURE OF CARDIOVASCULAR DRUGS REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
FIGURE 39 GLOBAL CARDIOVASCULAR DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004 2011 ($ MILLIONS)
REPRODUCTIVE DRUG MARKET
MARKET REVENUE
TABLE 43 GLOBAL REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
FIGURE 40 GLOBAL REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)
ONCOLOGY DRUG AND DIAGNOSTICS MARKET
MARKET REVENUE
TABLE 44 GLOBAL ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
FIGURE 41 GLOBAL ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)
ANALGESIC MARKET
MARKET REVENUE
TABLE 45 GLOBAL ANALGESIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
FIGURE 42 GLOBAL ANALGESIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)
ANTIVIRAL DRUGS MARKET
MARKET REVENUE
TABLE 46 GLOBAL ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
FIGURE 43 GLOBAL ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004 2011 ($ MILLIONS)
ANTIBIOTICS MARKET
MARKET REVENUE
TABLE 47 GLOBAL ANTIBIOTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
FIGURE 44 GLOBAL ANTIBIOTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)
MARKET FOR OTHER DRUGS
MARKET REVENUE
TABLE 48 GLOBAL OTHER DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)
FIGURE 45 GLOBAL OTHER DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ BILLIONS)
PATENT ANALYSIS
PATENTS BY YEAR
TABLE 49 NUMBER OF PATENTS BY YEAR, 2005-2007
FIGURE 46 NUMBER OF PATENTS BY YEAR, 2005-2007
FIGURE 47 NUMBER OF PATENTS BY YEAR, 2005-2007 (%)
PATENTS BY COMPANY
TABLE 50 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2007
FIGURE 48 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2007
PATENTS BY COUNTRY
TABLE 51 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2007
FIGURE 49 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2007
TABLE 52 PATENT SHARES BY COUNTRY, 2005-2007 (%)
FIGURE 50 PATENT SHARES BY COUNTRY, 2005-2007 (%)
PATENTS BY EMPHASIS
TABLE 53 PATENTS BY EMPHASIS, 2005-2007
FIGURE 51 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2007
SIGNIFICANT PATENTS OF 2006
TABLE 54 SIGNIFICANT PATENTS IN RESEARCH AND DEVELOPMENT, 2006
TABLE 54 (CONTINUED)
TABLE 55 SIGNIFICANT PATENTS IN DRUG DELIVERY, 2006
TABLE 55 (CONTINUED)
CURRENT ENVIRONMENT
CURRENT ENVIRONMENT
THE NEED
HOW MUCH AND WITH WHOM
OPEN OPTIONS
GLOBALIZATION FROM WEST TO EAST
CURRENT EUROPEAN CONTRACT MANUFACTURING
ENVIRONMENT
OUTSOURCING CHALLENGES FOR VIRTUAL
PHARMACEUTICAL COMPANIES
LEGAL CONTRACT-BID WORK
VENDOR SELECTION
COMMON MISTAKES MADE BY VIRTUAL COMPANIES IN
VENDOR SELECTION
PROJECT MANAGEMENT
COMPANY PROFILES
AAIPHARMA, INC.
ADVANCED POLYMER PHARMA, INC. (A.P. PHARMA)
AEROGEN, INC
ALBANY MOLECULAR RESEARCH, INC.
ALCAN PACKAGING
ALKERMES
ALMAC
ALPHARMA USPD, INC
ALZA CORP. (J&J CO.)
AMCOR LIMITED
APPTEC LABORATORIES
APTUIT
ARADIGM CORP
ASTER-CEPHAC
ATRIX LABORATORIES (QLT)
BAXTER PHARMACEUTICAL SOLUTIONS
BEN VENUE LABORATORIES (SUBSIDIARY OF BOEHRINGER
INGELHEIM)
BIORELIANCE CORP. (AVISTA CAPITAL PARTNERS)
CAMBREX CORP.
CANGENE
CARBOGEN AMCIS AG
CARDINAL HEALTH
CEDARBURG PHARMACEUTICALS, LTD
CHEMBRIDGE CORP
CONFAB LABORATORIES
DAVOS CHEMICAL CORP
DECODE GENETICS
DIOSYNTH RTP
DOWPHARMA
DPT LABORATORIES, LTD
DR. REDDY’S LABORATORIES
DSM PHARMACEUTICALS
EVOTEC AG
FULCRUM PHARMA, PLC
GENZYME PHARMACEUTICALS
GILEAD
GIRINDUS
GLAXOSMITHKLINE BIOPHARMACEUTICALS
HOVIONE S.A
ICOS CORP.
KV PHARMACEUTICAL CO
LYNE LABORATORIES
MALLINCKRODT PHARMACEUTICALS (OUTSOURCING)
MDS PHARMA SERVICES
MEDAREX, INC.
MIKART
MOVA PHARMACEUTICAL CORP
NICHOLAS PIRAMAL INDIA, LTD.
NOVAVAX, INC
ORTEC, INC
OSG NORWICH PHARMACEUTICALS
PATHEON
PHARMACOPEIA DRUG DISCOVERY, INC
PRECISION PHARMA SERVICES
QUINTILES, INC.
RANBAXY RESEARCH LABS
REGIS TECHNOLOGIES, INC.
SCHWARZ PHARMA
SKYEPHARMA
TETRIONICS, INC.
XCELLEREX, LLC
APPENDIX I. ABBREVIATIONS
LIST OF TABLES
SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE FORECAST, THROUGH 2011 ($ BILLIONS)
TABLE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2006 (%)
TABLE 1 (CONTINUED)
TABLE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2006 (%)
TABLE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID DOSAGE FORMS, 2006 (%)
TABLE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2006 (%)
TABLE 5 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2006 (%)
TABLE 6 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2006 (%)
TABLE 7 SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS
TABLE 8 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE
TABLE 9 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING REVENUE FORECAST BY REGION THROUGH 2011 ($ BILLIONS)
TABLE 10 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
TABLE 11 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)
TABLE 12 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
TABLE 13 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, THROUGH 2011 ($ BILLIONS)
TABLE 14 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
TABLE 15 GLOBAL LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2011 ($ MILLIONS)
TABLE 16 GLOBAL LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
TABLE 17 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST, BY REGION, THROUGH 2011 ($ MILLIONS)
TABLE 18 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
TABLE 19 GLOBAL LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING REVENUE FORECAST, BY FORMULATION, THROUGH 2011 ($ MILLIONS)
TABLE 20 GLOBAL LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
TABLE 21 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, THROUGH 2011 ($ MILLIONS)
TABLE 22 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
TABLE 23 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
TABLE 24 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
TABLE 25 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, THROUGH 2011 ($ MILLIONS)
TABLE 26 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
TABLE 27 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS
TABLE 28 GLOBAL CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE FORECAST BY TYPE, THROUGH 2011 ($ BILLIONS)
TABLE 29 GLOBAL ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING SHARE BY TYPE, 2006 (%)
TABLE 30 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)
TABLE 31 GLOBAL OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
TABLE 32 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE FORECAST BY DOSAGE FORM, THROUGH 2011 ($ BILLIONS)
TABLE 33 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2006 (%)
TABLE 34 GLOBAL CONTRACT PHARMACEUTICAL RESEARCH MARKET FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)
TABLE 35 GLOBAL CONTRACT RESEARCH MARKET SHARES BY REGION, 2006 (%)
TABLE 36 GLOBAL CONTRACT RESEARCH REVENUE FORECAST BY DISCIPLINE, THROUGH 2011 ($ BILLIONS)
TABLE 37 GLOBAL CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2006 (%)
TABLE 38 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)
TABLE 39 GLOBAL CONTRACT PACKAGING MARKET SHARES BY REGION, 2006 (%)
TABLE 40 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY PACKAGE TYPE, THROUGH 2011 ($ BILLIONS)
TABLE 41 GLOBAL CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2006 (%)
TABLE 42 GLOBAL CONTRACT MANUFACTURE OF CARDIOVASCULAR DRUGS REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
TABLE 43 GLOBAL REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
TABLE 44 GLOBAL ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
TABLE 45 GLOBAL ANALGESIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
TABLE 46 GLOBAL ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
TABLE 47 GLOBAL ANTIBIOTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ MILLIONS)
TABLE 48 GLOBAL OTHER DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, THROUGH 2011 ($ BILLIONS)
TABLE 49 NUMBER OF PATENTS BY YEAR, 2005-2007
TABLE 50 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2007
TABLE 51 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2007
TABLE 52 PATENT SHARES BY COUNTRY, 2005-2007 (%)
TABLE 53 PATENTS BY EMPHASIS, 2005-2007
TABLE 54 SIGNIFICANT PATENTS IN RESEARCH AND DEVELOPMENT, 2006
TABLE 55 SIGNIFICANT PATENTS IN DRUG DELIVERY, 2006
LIST OF FIGURES
SUMMARY FIGURE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2004-2011 (BILLIONS)
FIGURE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2006 (%)
FIGURE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2006 (%)
FIGURE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID DOSAGE FORMS, 2006 (%)
FIGURE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2006 (%)
FIGURE 5 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2006 (%)
FIGURE 6 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2006 (%)
FIGURE 7 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ BILLIONS)
FIGURE 8 GLOBAL BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 9 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 (BILLIONS)
FIGURE 10 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 11 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, 2004-2011 ($ BILLIONS)
FIGURE 12 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING, MARKET SHARES BY FORMULATION, 2006 (%)
FIGURE 13 GLOBAL LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2004-2011 ($ MILLIONS)
FIGURE 14 GLOBAL LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 15 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST, BY REGION, THROUGH 2011 ($ MILLIONS)
FIGURE 16 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 17 GLOBAL LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2004-2011 ($ MILLIONS)
FIGURE 18 GLOBAL LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
FIGURE 19 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, 2004-2011 ($ MILLIONS)
FIGURE 20 GLOBAL LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
FIGURE 21 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)
FIGURE 22 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 23 GLOBAL SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE FORECAST BY FORMULATION, 2004-2011 ($ MILLIONS)
FIGURE 24 GLOBAL SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2006 (%)
FIGURE 25 GLOBAL ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE FORECAST BY TYPE, 2004-2011 ($ BILLIONS)
FIGURE 26 GLOBAL ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2006 (%)
FIGURE 27 GLOBAL OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ BILLIONS)
FIGURE 28 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
FIGURE 29 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE FORECAST BY DOSAGE FORM, 2004-2011 ($ BILLIONS)
FIGURE 30 GLOBAL OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2006 (%)
FIGURE 31 GLOBAL CONTRACT PHARMACEUTICAL RESEARCH MARKET FORECAST BY REGION, 2004-2011 ($ BILLIONS)
FIGURE 32 GLOBAL CONTRACT RESEARCH MARKET SHARES BY REGION, 2006 (%)
FIGURE 33 GLOBAL CONTRACT RESEARCH REVENUE FORECAST BY DISCIPLINE, 2004-2011 ($ BILLIONS)
FIGURE 34 GLOBAL CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2006 (%)
FIGURE 35 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY REGION, 2004-2011 ($ BILLIONS)
FIGURE 36 GLOBAL CONTRACT PACKAGING MARKET SHARES BY REGION, 2006 (%)
FIGURE 37 GLOBAL CONTRACT PACKAGING MARKET FORECAST BY PACKAGE TYPE, 2004-2011 ($ BILLIONS) FIGURE 38 GLOBAL CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2006 (%)
FIGURE 39 GLOBAL CARDIOVASCULAR DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004 2011 ($ MILLIONS)
FIGURE 40 GLOBAL REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)
FIGURE 41 GLOBAL ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)
FIGURE 42 GLOBAL ANALGESIC CONTRACT
MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)
FIGURE 43 GLOBAL ANTIVIRAL DRUG CONTRACT
MANUFACTURING REVENUE FORECAST BY REGION, 2004 2011 ($ MILLIONS)
FIGURE 44 GLOBAL ANTIBIOTIC CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ MILLIONS)
FIGURE 45 GLOBAL OTHER DRUG CONTRACT MANUFACTURING REVENUE FORECAST BY REGION, 2004-2011 ($ BILLIONS)
FIGURE 46 NUMBER OF PATENTS BY YEAR, 2005-2007
FIGURE 47 NUMBER OF PATENTS BY YEAR, 2005-2007 (%)
FIGURE 48 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2007
FIGURE 49 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2007
FIGURE 50 PATENT SHARES BY COUNTRY, 2005-2007 (%)
FIGURE 51 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2007
For full details, please email keithw@cmsinfo.com
Top of Page
Buy now!
Top of Page
|
|
